Dr. Lal PathLabs Limited Stock

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Delayed NSE India S.E. 12:33:30 2024-07-19 am EDT 5-day change 1st Jan Change
3,012 INR +0.75% Intraday chart for Dr. Lal PathLabs Limited +2.05% +16.82%
Sales 2025 * 24.98B 299M Sales 2026 * 28.05B 335M Capitalization 249B 2.97B
Net income 2025 * 4.21B 50.39M Net income 2026 * 4.94B 59.01M EV / Sales 2025 * 9.53 x
Net cash position 2025 * 10.65B 127M Net cash position 2026 * 14.35B 172M EV / Sales 2026 * 8.35 x
P/E ratio 2025 *
59.3 x
P/E ratio 2026 *
50.5 x
Employees 4,099
Yield 2025 *
0.68%
Yield 2026 *
0.75%
Free-Float 43.47%
More Fundamentals * Estimated data
Dynamic Chart
1 day+0.75%
1 week+2.05%
Current month+8.29%
1 month+12.40%
3 months+36.31%
6 months+23.02%
Current year+16.82%
More quotes
1 week
2 955.00
Extreme 2955
3 055.00
1 month
2 631.55
Extreme 2631.55
3 055.00
Current year
1 943.70
Extreme 1943.7
3 055.00
1 year
1 943.70
Extreme 1943.7
3 055.00
3 years
1 762.05
Extreme 1762.05
4 245.50
5 years
1 054.00
Extreme 1054
4 245.50
10 years
696.50
Extreme 696.5
4 245.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-06-30
Director of Finance/CFO - 05-12-31
Chairman 74 95-02-13
Members of the board TitleAgeSince
Director/Board Member 58 23-07-26
Director/Board Member 77 15-08-20
Chairman 74 95-02-13
More insiders
Date Price Change Volume
24-07-19 3,012 +0.75% 125 239
24-07-18 2,989 -0.30% 349,847
24-07-16 2,998 +0.04% 308,256
24-07-15 2,997 +1.56% 424,835
24-07-12 2,951 +0.15% 112,474

Delayed Quote NSE India S.E., July 19, 2024 at 12:33 am EDT

More quotes
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
2,989 INR
Average target price
2,588 INR
Spread / Average Target
-13.43%
Consensus
  1. Stock Market
  2. Equities
  3. LALPATHLAB Stock